Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$46 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-9.9 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
17.8
Industry P/E
--
EV/EBITDA
-3
Div. Yield
0 %
Debt to Equity
--
Book Value
$0.1
EPS
$-0.6
Face value
--
Shares outstanding
41,087,871
CFO
$132.45 Mln
EBITDA
$178.58 Mln
Net Profit
$41.75 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Heartbeam Inc (BEAT)
| -50.8 | -21.9 | -50.8 | -41.0 | -19.6 | -- | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Heartbeam Inc (BEAT)
| 4.3 | -2.1 | -51.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Heartbeam Inc (BEAT)
|
1.2 | 46.0 | 0.0 | -21.0 | -- | -987.3 | -- | 17.8 |
| 4.2 | 7,561.4 | 3.0 | -816.0 | -29,333.3 | -40.6 | -- | 3.8 | |
| 51.4 | 6,916.7 | 900.8 | 109.2 | 21.9 | 58.1 | 45.9 | 27.4 | |
| 23.8 | 7,112.9 | 731.4 | -38.8 | 1.5 | -2.6 | -- | 3.5 | |
| 8.2 | 8,586.8 | 12,149.6 | 4,288.1 | 6.7 | 11 | 13.5 | 1.5 | |
| 39.9 | 7,868.8 | 11,120.8 | 923.8 | 22.6 | 3.7 | 62.3 | 2.2 | |
| 84.7 | 6,961.4 | 1,313.4 | 215.2 | 24.6 | 10.2 | 33.1 | 3.2 | |
| 42.6 | 7,040.1 | 1,745.8 | 393.4 | 16.1 | 57.3 | 19.5 | 8.6 | |
| 13.0 | 7,323.8 | 1,071.4 | -270.1 | -28.1 | -42.9 | -- | 1.1 | |
| 22.8 | 9,926.5 | 1,849.7 | -402.8 | -20.4 | -12.5 | -- | 3.0 |
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops... HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California. Address: 2118 Walsh Avenue, Santa Clara, CA, United States, 95050 Read more
Executive Chairman
Mr. Richard M. Ferrari
Executive Chairman
Mr. Richard M. Ferrari
Headquarters
Santa Clara, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Heartbeam Inc (BEAT) is $1.18 (NASDAQ) as of 02-Apr-2026 19:59 EDT. Heartbeam Inc (BEAT) has given a return of -19.59% in the last 3 years.
Since, TTM earnings of Heartbeam Inc (BEAT) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-3.88
|
31.35
|
|
2024
|
-3.19
|
37.55
|
|
2023
|
-3.21
|
2.95
|
|
2022
|
-3.04
|
16.44
|
|
2021
|
-2.78
|
0.92
|
The 52-week high and low of Heartbeam Inc (BEAT) are Rs 4.00 and Rs 0.54 as of 05-Apr-2026.
Heartbeam Inc (BEAT) has a market capitalisation of $ 46 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Heartbeam Inc (BEAT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.04
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.